Essex Investment Management CO LLC Myriad Genetics Inc Transaction History
Essex Investment Management CO LLC
- $516 Million
- Q4 2024
A detailed history of Essex Investment Management CO LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Essex Investment Management CO LLC holds 116,709 shares of MYGN stock, worth $1.14 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
116,709
Previous 235,841
50.51%
Holding current value
$1.14 Million
Previous $6.45 Million
75.21%
% of portfolio
0.31%
Previous 1.2%
Shares
3 transactions
Others Institutions Holding MYGN
# of Institutions
227Shares Held
86MCall Options Held
297KPut Options Held
20.7K-
Black Rock Inc. New York, NY15.2MShares$147 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$103 Million0.0% of portfolio
-
State Street Corp Boston, MA5.53MShares$53.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.35MShares$42.3 Million0.03% of portfolio
-
Glenview Capital Management, LLC New York, NY4.16MShares$40.5 Million1.44% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $785M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...